Riskpilot← Back to searchSign inGet full accessAceso Nordic ApS
APSActiveCVR 41665599Lærkevej 9Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20203 employees
Revenue 2025
DKK 1,8M
-16% vs 2024
EBITDA margin
19.3%
-24% vs 2024
Equity ratio
83.0%
Financial strength
Net profit 2025
DKK 270K
-25% vs 2024
| Revenue | DKK 1,8M | -16% |
| EBITDA | DKK 346K | -24% |
| Net profit | DKK 270K | -25% |
| Total assets | DKK 1M | -10% |
| Equity | DKK 832K | -9% |
| Employees | 3 | — |
Legal name
Aceso Nordic ApS
CVR number
41665599
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9. september 2020
Share capital
DKK 40.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at drive konsulentvirksomhed samt virksomhed med rådgivning, salg, distribution og markedsføring af lægemidler, medicinsk udstyr, personlig pleje, vitaminer, kosttilskud, naturlægemidler og CE-mærkede produkter samt anden virksomhed, der står i forbindelse hermed.
Address
Lærkevej 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.461 | 2.264 | 2.316 | 2.127 | 1.797 |
| Staff expenses | -1.472 | -1.543 | -1.847 | -1.670 | -1.451 |
| EBITDA | 989 | 721 | 469 | 458 | 346 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 989 | 721 | 469 | 458 | 346 |
| Net financials | -11 | -9 | -0 | 3 | 2 |
| Profit before tax | 979 | 712 | 468 | 460 | 348 |
| Tax | 216 | 157 | 103 | 102 | 78 |
| Net profit | 762 | 555 | 365 | 358 | 270 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 931 | 1.100 | 1.078 | 1.109 | 1.002 |
| Equity | 803 | 988 | 853 | 911 | 832 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 128 | 112 | 225 | 198 | 170 |
| Total debt | 128 | 112 | 225 | 198 | 170 |
EBITDA margin
19.3%
This company
15.8%
Market median
+22% vs market
20212025
Equity ratio
83.0%
This company
38.2%
Market median
+117% vs market
20212025
Return on equity
32.5%
This company
18.4%
Market median
+77% vs market
20212025
Net profit margin
15.0%
This company
8.1%
Market median
+85% vs market
20212025
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
20212025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-09-09 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HS Management | Management | 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Epione Group ApS
Aceso Nordic ApS Board members of Aceso Nordic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henriette Sidenius | Management | 0 companies |